« Previous
Next »
Journal of Vascular Surgery
Volume 52, Issue 2
, Pages 356-361
, August 2010
Below knee bare nitinol stent placement in high-risk patients with critical limb ischemia is still durable after 24 months of follow-up
References
- . Bypass versus angioplasty in severe ischemia of the leg vices (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366:1925–1934
- . Primary stent-supported angioplasty for treatment of below-knee critical limb ischemia and severe claudication. J Am Coll Cardiol. 2004;44:2307–2314
- PTA versus carbofilm-coated stents in infrapopliteal arteries: pilot study. Cardiovasc Intervent Radiol. 2006;29:29–38
- . Percutaneous transluminal angioplasty for treatment of “below-the-knee” critical limb ischemia: early outcomes following the use of sirolimus-eluting stents. J Cardiovasc Surg. 2006;47:171–176
- Self-expandable stent placement in infrapopliteal arteries after unsuccessful angioplasty failure: one-year follow-up. Cardiovasc Intervent Radiol. 2008;31:860–864
- . First clinical application of absorbable metal stents in the treatment of critical limb ischemia: 12-month results. Vasc Dis Manage. 2005;2:86–91
- . Nitinol stenting for treatment of “below-the-knee'' critical limb ischemia: 1-year angiographic outcome after Xpert stent implantation. J Cardiovasc Surg. 2007;48:455–461
- TransAntlantic Inter-Society Consensus (TASC) on management of peripheral arterial disease (PAD). J Vasc Surg. 2000;31:1–296
- . Initial clinical experience with the 4-F self-expanding Xpert stent system for infrapopliteal treatment of patients with severe claudication and critical limb ischemia. J Vasc Interv Radiol. 2007;18:703–708
- . Sirolimus-eluting versus bare stents for bailout after suboptimal infrapopliteal angioplasty for critical limb ischemia: 6-month angiographic results from a nonrandomized prospective single-center study. J Endovasc Ther. 2005;12:685–695
- . Below knee bare nitinol stent placement for high-risk patients with critical limb ischemia and unlimited supragenicular inflow as treatment of choice. Eur J Vasc Endovasc Surg. 2009;37:688–693
- . Sirolimus-eluting stents for the treatment of obstructive superficial artery disease: six-month results. Circulation. 2002;106:1505–1509
- Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology. 2004;232:516–521
- Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation. 2007;29:2745–2749115
- Infragenicular stent implantation for below-the-knee atherosclerotic disease: clinical evidence from an international collaborative meta-analysis on 640 patients. J Endovasc Ther. 2009;16:251–260
- . Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009;16:153–162
- . Fracture of a drug-eluting stent in the tibioperoneal trunk following bifurcation stenting. J Endovasc Ther. 2007;14:106–109
- . Incidence, anatomical location, and clinical significance of compressions and fractures in infrapopliteal balloon expandable metal stent. J Endovasc Ther. 2009;16:15–22
Competition of interest: none.
The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a competition of interest.
PII: S0741-5214(10)00666-X
doi: 10.1016/j.jvs.2010.02.281
© 2010 Society for Vascular Surgery. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of Vascular Surgery
Volume 52, Issue 2
, Pages 356-361
, August 2010
